← Leaderboards
Wendy G. Mitchell
University Of Southern California
$221,419
Attributed
$221,419
Total exposure
6
Grants
4
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding over time
peak $8.7K · FY2005–08$10K$7.5K$5K$2.5K$0
'05
'06
'07
'08
Funding mix
By agency
NIH$221,419 · 6
By mechanism
M01$221,419 · 6
Top collaborators
No co-investigators on record.
Most similar at University Of Southern California
Same institution · by research overlap
- David Ko$2,344,909
- Andrea A. Kovacs$11,647,115
- Dominique Duncan$3,859,074
- Terence John O'Brien$1,261,869
- Gregory Y Chang$347,081
Others in their field
Top investigators on “Generalized Seizures”
- Daniel Lowenstein · Beth Israel Deaconess Medical Center$26,416,844
- Shlomo Shinnar · Montefiore Medical Center (Bronx, Ny)$15,863,551
- John R Huguenard · Stanford University$12,095,460
- David A. Greenberg · Mount Sinai School Of Medicine Of Nyu$11,746,388
- Tracy A Glauser · Children'S Hospital Med Ctr (Cincinnati)$11,724,630
- Andrew G Herzog · Beth Israel Deaconess Medical Center$10,510,436
Research focus
Generalized SeizuresClinical ResearchHuman SubjectHuman Therapy EvaluationDrug Screening /EvaluationSpasmEpilepsyInfant Human (0-1 Year)Brain Disorder ChemotherapyChild (0-11)AnticonvulsantsConditionExcisionFundingGrantImage ProcessingImmunosuppressive AgentsInstitutionMagnetic Resonance SpectroscopyModalityMorphometryMotorNeuroblastomaNeuroimaging
Grant awards (10)
MR SPECTROSCOPY & VOXEL-BASED MORPHOMETRY OF THE CEREBELLUM IN LONG-TERM$8,411
M01 · FY2008 · RR · contact PI
MR SPECTROSCOPY & VOXEL-BASED MORPHOMETRY OF THE CEREBELLUM IN LONG-TERM$6,783
M01 · FY2007 · RR · contact PI
MR SPECTROSCOPY & VOXEL-BASED MORPHOMETRY OF THE CEREBELLUM IN LONG-TERM$6,532
M01 · FY2006 · RR · contact PI
PILOT STUDY: OPSOCLONUS ATAXIA (OA)$2,178
M01 · FY2006 · RR · contact PI
MR SPECTROSCOPY &VOXEL-BASED MORPHOMETRY OF THE CEREBELLUM IN LONG-TERM$6,198
M01 · FY2005 · RR
CLINICAL EXPERIENCE AND USE OF VIGABATRIN IN PATIENTS WITH INFANTILE SPASMS$0
M01 · FY2002 · RR
CLINICAL EXPERIENCE AND USE OF VIGABATRIN IN PATIENTS WITH INFANTILE SPASMS$155,764
M01 · FY2001 · RR
CLINICAL EXPERIENCE AND USE OF VIGABATRIN IN PATIENTS WITH INFANTILE SPASMS$0
M01 · FY2001 · RR
CLINICAL EXPERIENCE AND USE OF VIGABATRIN IN PATIENTS WITH INFANTILE SPASMS$35,553
M01 · FY2000 · RR
CLINICAL EXPERIENCE AND USE OF VIGABATRIN IN PATIENTS WITH INFANTILE SPASMS$0
M01 · FY2000 · RR